HSPA12A and myocardial infarction: In line with the reduced capillary density, Hspa12a−/− mice demonstrated worsened cardiac dysfunction as indicated by lower left ventricular ejection fraction (EF%) and fraction shortening (FS%) than WT mice after MI for 14 days (Figure 11(e)).